Fundación GAIKER

GAIKER has a great experience in the development of novel in vitro-based technologies to assist Safeby-design (SbD) and Risk Assessment (RA) of Nanomaterials and nanobased products development. Our experience is based on our participation and leading roles in International Projects dealing with safety and efficacy assessment of nano-based products. 

The Biotechnology area at GAIKER is a member of the IVTIP (European in vitro testing industrial platform) and is also an active member of the NanoSafety Cluster and the European Technology Platform for NanoMedicine. Since 2013 Fundación GAIKER belongs to the EURL-ECVAM group of laboratories for the validation of alternative methodologies within the EU.